My role in HYMS is to act as Director of the Skin Research Centre. Maintaining and developing externally-funded programmes of independent and internationally competitive research on the skin is of primary importance. I provide leadership in the Centre’s research strategy where I am keen to see interdisciplinary research thrive. Translational research underpinned by basic science discoveries is a key aspect that I believe will drive collaboration across the Medical School, YBRI and beyond. Teaching within the Medical School and University enables the Centre to take part in training the next generation of clinicians and scientists.
Professor Prow has £6.5m in open grants in research programs that include early melanoma diagnostic technologies, skin cancer treatment, and the study of the consequences of environmental contaminant exposure to skin. He also has an extensive industry collaboration, commercialisation, and licensing portfolio. Of note artificial intelligence (AI) and molecular diagnostics represent an area of significant innovation opportunity and funding in dermatology. In this respect, Prof Prow has also been working in the field of skin cancer utilising AI for triaging lesions for molecular diagnostic informed disease management.
Prof Prow has research programs that include early melanoma diagnostic technologies, skin cancer treatment, and the study of the consequences of environmental contaminant exposure to skin. He is investigating the combination of artificial intelligence (AI) and molecular diagnostics for molecular diagnostic informed disease management.
The Prow lab is currently recruiting students to work on projects including:
- melanoma diagnostic technologies
- novel skin cancer treatment
- environmental contaminant exposure to skin
- artificial intelligence for skin disease detection
Professor, Future Industries Industries Institute, Adelaide, Australia; Chief Scientific Officer, Founder and Director, Estrenue Pty Ltd, Adelaide, Australia; Director, Biopsy Solutions Pty Ltd, Melbourne, Australia.